Intra-Mesenteric Artery Steroid Administration Relieved Severe Refractory Gastro-Intestinal Graft-Vs.-Host Disease in an Allogeneic Bone Marrow Transplantation Patient

American Journal of Hematology

Volumn 56, Issue 4, 1997, Pages 277-280

  Sato, Tsutomu ^a   Sakamaki, Sumio ^a   Nagaoka, Yasuhiro ^a   Kuribayashi, Kageaki ^a   Nagamachi, Yasuhiro ^a   Morii, Kazuhiro ^a   Honma, Hisato ^a   Kogawa, Katsuhisa ^a   Kato, Junji ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Graft vs. host disease; Intraarterial injection; Steroid; Therapy; Ulcerative colitis

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ADULT; ALLOTRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; GRAFT VERSUS HOST REACTION; HUMAN; INTESTINE MUCOSA; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MESENTERIC ARTERY; PATHOLOGY; SKIN; ULCERATIVE COLITIS;

ADULT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; COLITIS, ULCERATIVE; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INTESTINAL MUCOSA; MALE; MESENTERIC ARTERIES; PREDNISOLONE; SKIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031436374     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199712)56:4<277::AID-AJH14>3.0.CO;2-6     Document Type: Article

References (11)

1. Beatty PG, Hansen JA, Longton GM, Thomas ED, Sanders JE, Martin PJ, Bearman SI, Anasetti C, Petersdorf EW, Mickelson EM: Marrow transplantation from HLA matched unrelated donors for treatment of hematologic malignancies. Transplantation 51:443, 1991.
2. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee DJ, McCullough J: Analysis of 462 transplantation from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993.
3. Vowels MR, Lam PTR, Brown R: Bone marrow transplantation: A review of a programme and its first 100 patients. Med J Aust 19:580, 1990.
4. Darmstadt GL, Donnenberg AD, Vogelsang GB, Farmer ER, Horn TD: Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft versus host disease. J Invest Dermatol 99:397, 1992.
5. Weisdorf D, Haake R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A: Treatment of moderate/severe acute graft versus host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome. Blood 75:1024, 1990.
6. Mcdonald JF: The human gastrointestinal tract after allogeneic marrow transplantation. In: "The Pathology of Bone Marrow Transplantation." New York: Masson Publishing, pp 7-10, 1986.
7. Roy J, McGlave PB, Filipovich AH, Miller WJ, Blazer BR, Ramsay NK, Kersey JH, Weisdorf DJ: Acute graft versus host disease following unrelated donor marrow transplantation: Failure of conventional therapy. Bone Marrow Transplant 10:77, 1992.
8. Ferrara JL: Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol 5:794, 1993.
9. Ferrara JL, Deeq HJ: Graft versus host disease. N Engl J Med 324:667, 1991.
10. Barak V, Levin SF, Nisman B, Nagler A: Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma 17:169, 1995.
11. Hiramatsu K, Asakura H, Baba S: Selective intraarterial steroid injection in ulcerative colitis. Acta Radiol Diagn Stockh 17:229, 1976.